10.01.2011 • NewsJohnson & Johnson

Smith & Nephew Rejects $11 Billion Bid from Johnson & Johnson

British medical equipment company Smith & Nephew rejected a 7 billion pound ($10.9 billion) takeover approach from U.S. rival Johnson & Johnson late last year, Sky News said, without citing sources.

Sky said Johnson & Johnson (J&J) was considering whether to return with a higher offer, after its indicative bid of more than 750 pence a share was turned down as too low.

No one at Smith & Nephew (S&N), which is regularly tipped as a bid target for U.S. rivals such as privately owned Biomet, was immediately available for a comment. Bill Price, a J&J spokesman, said the company as a matter of policy does not comment on "rumors and speculation."

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.